Effects of formoterol and BRL 37344 on human umbilical arteries in vitro in normotensive and pre-eclamptic pregnancy

Vascular Pharmacology

Volumn 46, Issue 5 SPEC. ISS., 2007, Pages 360-366

  Karadas, Baris ^a   Kaya, Tijen ^b   Cetin, Meral ^c   Parlak, Ahmet ^b   Durmus, Nedim ^b   Bagcivan, Ihsan ^b   Gulturk, Sefa ^d  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Department of Pharmacology University School of Medicine ^*  (Turkey)

^c Gynecology University School of Medicine   (Turkey)

^d CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

BRL 37344; cAMP; Formoterol; Pre eclampsia

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; CYCLIC AMP; FORMOTEROL; METOPROLOL; PHENYLEPHRINE; RECEPTOR SUBTYPE;

ADULT; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY TONE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PREECLAMPSIA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; UMBILICAL ARTERY;

EID: 33847691952     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.12.002     Document Type: Article

References (40)

1. August P., and Lindheimer M.D. Pathophysiology of preeclampsia. In: J.H., and Brenner B.M. (Eds). Hypertension, Pathophysiology, Diagnosis, and Management (1995), Raven, New York 2407-2426
2. 3-and a typical β-adrenoreceptors. Med. Res. Rev. 13 (1993) 663-729
3. Arch J.R.S. The brown adipocyte b-adrenoceptor. Proc. Nutr. Soc. 48 (1989) 215-233
4. 2-adrenoceptor signal system in preeclampsia. Br. J. Obstet. Gynaecol. 107 (2000) 116-121
5. Blue D.R., Bond R.A., Adham N., Delmondo R., Michel A.I., Eglin R.M., Whiting R.L., and Clarke D.E. Interaction of dihydroalprenolol and cyanopindolol with atypical b-adrenoceptors in guinea-pig ileum. Br. J. Pharmacol. 96 (1989) 246
6. Cazzola, M., Mantero, A., Santus, P., Carlucci, P., Mondoni, M., Bosotti, L., Centanni, S., in press. Doppler echocardiographic assessment of the effects of inhaled long-acting beta(2)-agonists on pulmonary artery pressure in COPD patients. Pulm. Pharmacol. Ther. (Electronic publication ahead of print).
7. Challiss R., Leighton B., Wilson S., Thurlby P.L., and Arch J.R.S. An investigation of the b-adrenoceptor that mediates metabolic responses to the novel agonist BRL 29410 in rat soleus muscle. Biochem. Pharmacol. 37 (1988) 947-950
8. 2+ release. Am. J. Physiol. 271 (1996) 962-968
9. Davey D.A., and Macnab M.F. Plasma adrenaline, noradrenaline and dopamine in pregnancy hypertension. Br. J. Obstet. Gynaecol. 88 (1981) 611-618
10. Dennedy M.C., Houlihan D.D., McMillan H., and Morrison J.J. Beta2- and beta3-adrenoreceptor agonists: human myometrial selectivity and effects on umbilical artery tone. Am. J. Obstet. Gynecol. 187 (2002) 641-647
11. 3-adrenoceptors in the cardiovascular system. Trends Pharmacol. Sci. 21 (2000) 426-431
12. Hedberg A., Kempf F.J., Josephson M.E., and Molinoff P.B. Coexistence of beta-1 and beta-2 adrenergic b3-adrenergic pulmonary vasodilation 331 receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers. J. Pharmacol. Exp. Ther. 234 (1985) 561-568
13. 2+ mobilization in smooth muscle of rabbit mesenteric artery. Br. J. Pharmacol. 110 (1993) 1117-1125
14. Kaumann A.J., and Lynham J.A. Stimulation of cyclic AMP-dependent protein kinase in rat atria by (-)-CGP 12177 through an atypical b-adrenoceptor. Br. J. Pharmacol. 120 (1997) 1187-1189
15. Kuriyama H., Kitamura K., Itoh T., and Inoue R. Physiological features of visceral smooth muscle cells, with special reference to receptors and ion channels. Physiol. Rev. 78 (1998) 811-920
16. Lands A.M., Luduena F.P., and Buzzo H.J. Differentiation of receptors responsive to isoproterenol. Life Sci. 6 (1967) 2241-2249
17. Lenfant C., Gifford J.R.R.W., and Zuspan F.P. National high blood pressure education program working group report on high blood pressure in pregnancy. Am. J. Obstet. Gynecol. 163 (1990) 1691-1712
18. Levine R.J., Thadhani R., Qian C., Lam C., Lim K.H., Yu K.F., Blink A.L., Sachs B.P., Epstein F.H., Sibai B.M., Sukhatme V.P., and Karumanchi S.A. Urinary placental growth factor and risk of preeclampsia. JAMA 293 (2005) 77-85
19. Manyonda I.T., Slater D.M., Fenske C., Hole D., Choy M.Y., and Wilson C. A role for noradrenaline in preeclampsia: towards a unifying hypothesis for the pathophysiology. Br. J. Obstet. Gynaecol. 105 (1998) 641-648
20. 3-adrenoceptors) mediating relaxation in the rat distal colon in vitro. Br. J. Pharmacol. 101 (1990) 569-574
21. McLaughlin D.P., and MacDonald A. Characterization of catecholamine-mediated relaxations in rat isolated fundus: evidence for an atypical b-adrenoceptors. Br. J. Pharmacol. 10 (1991) 1351-1356
22. Nisell H., Martinsson A., and Hjemdahl P. Reduced beta 2-adrenoceptor sensitivity in normal pregnancy but not in pregnancy-induced hypertension. Gynecol. Obstet. Investig. 25 (1988) 262-267
23. Ohashi M., Dohi Y., and Itoh T. Possible mechanisms underlying the vasodilatation induced by olprinone, a phospho-diesterase III inhibitor, in rabbit coronary artery. Br. J. Pharmacol. 129 (2000) 1000-1006
24. O'Shaughnessy R., Reiss R., Scott-Tibbs G., and McSweeney E. Plasma and platelet norepinephrine in normal and preeclamptic pregnancy. J. Reprod. Med. 32 (1987) 504-508
25. Oian P., Kjeldsen S.E., Eide I., and Maltau J.M. Increased arterial catecholamines in pre-eclampsia. Acta Obstet. Gynecol. Scand. 65 (1986) 613-617
26. Pedersen E.B., Rasmussen A.B., Christensen N.J., Johannesen P., Lauritsen J.G., Kristensen S., and Wohlert M. Plasma noradrenaline and adrenaline in pre-eclampsia, essential hypertension in pregnancy and normotensive pregnant control subjects. Acta Endocrinol. 99 (1982) 594-600
27. Poppas A., Shroff S.G., Korcarz C.E., Hibbard J.U., Berger D.S., Lindheimer M.D., and Lang R.M. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation 95 (1997) 2407-2415
28. Rembold C.M., and Chen X.L. Mechanisms responsible for forskolin-induced relaxation of rat tail artery. Hypertension 31 (1998) 872-877
29. Rouget C., Barthez O., Goirand F., Leroy M.J., Breuiller-Fouche M., Rakotoniaina Z., Guerard P., Morcillo E.J., Advenier C., Sagot P., Cabrol D., Dumas M., and Bardou M. Stimulation of the ADRB3 adrenergic receptor induces relaxation of human placental arteries: influence of preeclampsia. Biol. Reprod. 74 (2006) 209-216
30. 3-adrenergic receptor regulation in conscious primates, rats and dogs. J. Pharmacol. Exp. Ther. 278 (1996) 1435-1443
31. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
32. Silver P.J., and Stull J.T. Regulation of myosin light chain and phosphorylase phosphorylation in tracheal smooth muscle. J. Biol. Chem. 257 (1982) 6145-6150
33. 3-adrenergic receptor. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 421-450
34. 3-adrenoreceptor. Trends Pharmacol. Sci. 17 (1996) 869-877
35. Tagaya E., Tamaoki J., Takemura H., Isono K., and Nagai A. Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cyclic adenosine monophosphate-dependent pathway. Lung 177 (1999) 321-332
36. Takeda H., Yamazaki Y., Akahane M., Igawa Y., Ajisawa Y., and Nishizawa O. Role of the beta(3)-adrenoreceptor in urine storage in the rat: comparison between the selective beta(3)-adrenoreceptor agonist, CL316,243 and various smooth muscle relaxants. J. Pharmacol. Exp. Ther. 293 (2000) 939-945
37. 3-adrenoceptor)-mediated relaxation of canine isolated bronchial smooth muscle. J. Appl. Physiol. 74 (1993) 297-302
38. Thadhani R., Mutter W.P., Wolf M., Levine R.J., Taylor R.N., Sukhatme V.P., Ecker J., and Karumanchi S.A. First-trimester placental growth factor and soluble FMS-like tyrosine kinase 1 and risk for preeclampsia. J. Clin. Endocrinol. Metab. 89 (2004) 770-775
39. Trochu J.N., Leblais V., Rautureau Y., Beverelli F., Le Marec H., Berdeaux A., and Gauthier C. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br. J. Pharmacol. 128 (1999) 69-76
40. Van Riper D.A., Weaver B.A., Stull J.T., and Rembold C.M. Myosin light chain kinase phosphorylation in swine carotid artery contraction and relaxation. Am. J. Physiol. 268 (1995) 2466-2475